KēlaHealth raises $13m for AI-powered surgical intelligence platform
KēlaHealth, a US-based healthcare data analytics company, has raised $12.9 million in a combined seed and Series A financing round for its artificial intelligence-powered surgical intelligence platform.
Santé Ventures and Intuitive Ventures led the Series A financing round, which included a grant from the US National Science Foundation Small Business Innovation Research (SBIR) Program.
The funds will speed up the expansion of the KēlaHealth platform to hospitals and surgical partners across the US.
KēlaHealth raises $12.9m for surgical intelligence platform. Logo courtesy of Nueterra Capital.
Details of the KēlaHealth surgical intelligence platform
KēlaHealth, which is owned by Nueterra Capital, provides patient-specific predictive insight and risk stratification software, which not only aids in improving surgical quality but also in preventing complications.
The surgical intelligence platform helps to prevent these avoidable complications by providing enhanced surgical care by using stratified patient risk scoring.
Oliver Keown – Director of Intuitive Ventures said: “KēlaHealth’s platform represents a powerful solution for providers and medical device partners looking to unlock the potential of data in pursuit of improved outcomes and lowering the cost of care.”
By using machine learning algorithms, the healthcare data analytics company is said to match individual risk levels with graduated pathways of care in line with the unique requirements of each surgical patient.
By leveraging the personalized approach of KēlaHealth, surgeons can match the right patient with the right procedure besides taking the appropriate precautions at the right time, which will yield improved patient outcomes and considerable hospital savings.
Bora Chang – CEO of KēlaHealth said: “Our vision is to apply the lessons learned from millions of previous surgeries for the benefit of every patient undergoing a procedure. Patients and their families, clinicians, and hospitals deserve the assurance that the risks of any surgery will be safely navigated by surgical teams with the best information available to them at every point in the surgical journey.
“We are thrilled to have a stellar group of surgeons, hospital centers, investors, and advisors working with us to realize the opportunity of precision surgery.”